1 Introduction
2 E-records Lifecycle Revisited
3 Data and E-records Lifecycles -- A Comparison
4 MHRA Guidance -- Revisited
5 E-records Integrity Expectations of EU GMP Inspectors
6 Comparison of Health Authorities E-records
Integrity Expectations
7 Maxims of E-records Integrity
8 Vulnerabilities of E-records
9 CGMP E-records Risk Management
10 CGMP E-records Risk Assessments
11 Security Service
12 Defining and Managing Manufacturing Data
13 Controls on Transient Data
14 Digital Date and Timestamps
15 E-records Migration and Its Integrity
16 Ensuring E-records Integrity of Cloud Service
Providers
17 E-records Integrity in Hybrid Systems
18 Technologies Supporting E-records Integrity
19 Integration Between Computer Systems and
E-records Lifecycles
20 Miscellaneous E-records Integrity Issues
21 E-records Remediation Project Revisited -- Medicine
Manufacturing
22 Designing E-records Integrity into your Practices
23 Introduction to Data Quality
24 Summary
N2 - Data integrity is a critical aspect to the design, implementation, and usage of any system which stores, processes, or retrieves data. The overall intent of any data integrity technique is the same: ensure data is recorded exactly as intended and, upon later retrieval, ensure the data is the same as it was when originally recorded. Any alternation to the data is then traced to the person who made the modification. The integrity of data in a patient's electronic health record is critical to ensuring the safety of the patient. This book is relevant to production systems and quality control systems associated with the manufacture of pharmaceuticals and medical device products and updates the practical information to enable better understanding of the controls applicable to e-records. The book highlights the e-records suitability implementation and associated risk-assessed controls, and e-records handling. The book also provides updated regulatory standards from global regulatory organizations such as MHRA, Medicines and Healthcare Products Regulatory Agency (UK); FDA, Food and Drug Administration (US); National Medical Products Association (China); TGA, Therapeutic Goods Administration (Australia); SIMGP, Russia State Institute of Medicines and Good Practices; and the World Health Organization, to name a few UR - https://www.taylorfrancis.com/books/9781003105695 UR - http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf ER -